The pharmaceutical drug market is all about production, development and manufacturing of drugs and medicinal compounds (Khanna, 2012). Medicinal compounds, on the other hand, include all active chemical or organic products with capabilities of eradication and control of diseases.
R&D investments are an important component for driving the sales and distribution of the pharmaceutical drug market (Pammolli, Magazzini, & Riccaboni, 2011).
According to a report by WHO, (2015) asthmatic drugs comprised approximately 30% of the overall drugs market. However, allergic cases such as drug hypersensitivities, food hypersensitivities, skin allergies, and others; lack a significant market share in spite of their rising prevalence.
Atopic dermatitis (eczema), an immune-mediated skin disease, continues to exhibit rising prevalence trends around the globe. As shown in the previous article, the worldwide patterns of the disease occurrence tend not to show any decline. The atopic dermatitis burden has also been stipulated to be on the rise due to associations with a number of co-morbidities.
Allergy is hypersensitivity of the immune system or abnormal reaction of the immune system to foreign antigens. Allergy-related common diseases include allergic rhinitis, urticaria, eczema, anaphylaxis, conjunctivitis, and asthma. Allergy may affect the lungs, stomach, skin, nose, throat, and eyes.